Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-019242-28Phase 4Active
Phase 4, randomised, double-blind trial of nitroglycerin in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Helios Park-Klinikum Leipzig. Primary endpoints: Time to angina threshold at ergometry and Time to ST-segment depression at ergometry. Started Mar 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-019242-28.